Company intelligence / Profile preview
Pylum Biosciences
South San Francisco, California, United Statespylumbio.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Pylum Biosciences has developed the Avidocin™ platform to generate bactericidal protein complexes that target specific bacterial pathogens with high specificity and minimal off-target effects. The company’s lead programs are in preclinical development targeting major human pathogens such as C. difficile, uropathogenic E. coli, K. pneumoniae, vancomycin-resistant Enterococcus, and Pseudomonas aeruginosa for indications including CDI prevention/treatment, complicated UTIs, bacteremia, and cystic fibrosis-related infections. Preclinical animal studies have shown impressive efficacy in multiple infection models.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Protein drugs (bactericidal protein complexes)Bacteriocins and pyocinsAvidocin™ proteinsPurocin™ proteins
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
Beyond the preview
Go deeper on Pylum Biosciences.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Pylum Biosciences.